Computational analysis of folding and mutation properties of C5 domain of myosin binding protein C

Proteins: Structure, Function and Genetics

Volumn 70, Issue 4, 2008, Pages 1313-1322

  Guardiani, Carlo ^a   Cecconi, Fabio ^b   Livi, Roberto ^c  

^a Dipartimento di Fisica   (Italy)

^b ISC CNR   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Folding; mutations; Myosin binding protein C; Natively unfolded proteins; Simulations

Indexed keywords

MYOSIN BINDING PROTEIN C;

ARTICLE; BETA SHEET; BIOINFORMATICS; CONFORMATIONAL TRANSITION; HYDROPHOBICITY; LIGAND BINDING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STABILITY; THERMODYNAMICS;

CARRIER PROTEINS; COMPUTATIONAL BIOLOGY; ELECTROSTATICS; HUMANS; HYDROPHOBICITY; MUTATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY;

EID: 39749148315     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21621     Document Type: Article

References (55)

1. Winegrad S. Myosin binding protein c, a potential regulator of cardiac contractility. Circ Res 2000;86:6-7.
2. Chung MW, Tsoutsman T, Semsarian C. Hypertrophic cardiomyopathy: from gene defect to clinical disease. Cell Res 2003;13:9-20.
3. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang T-H, Choo J-A, Chung K-S, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997;16:379-382.
4. Mogensen J, Klausen IC, Pedersen AK, Egeblad H, Bross P, Kruse TA, Gregersen N, Hansen PS, Baandrup U, Borglum AD. α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 1999;103:R39-R43.
5. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996;13:63-69.
6. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 1999;262:411-417.
7. Niimura H. Mutations in the gene for cardiac myosin-binding protein c and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998;338:1248-1257.
8. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet J-P, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003;107:2227-2232.
9. Charron P, Dubourg O, Desnos M, Isnard R, Hagege R, Bonne G, Carrier L, Teson F, Bouhour JB, Buzzi J-C, Feingold J, Schwartz K, Komajda M. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-c and the β-myosin heavy chain genes. Eur Heart J 1998;19:139-145.
10. Daehmlow S, Erdmann J, Knueppel T, Gille C, Froemmel C, Hummel M, Hetzer R, Regitz-Zagrosek V. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biophys Res Commun 2002;298:116-120.
11. Yu B, French JA, Carrier L, Jeremy RW, McTaggart DR, Nicholson MR, Hambly B, Semsarian C, Richmond DR, Schwartz K, Trent RJ. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein c gene. J Med Genet 1998;35:205-210.
12. Moolman-Smook J, Flashman E, de Lange W, Li ZL, Corfield V, Redwood C, Watkins H. Identification of novel interactions between domains of myosin binding protein-c that are modulated by hypertrophic cardiomyopathy missense mutations. Circ Res 2002;91:704-711.
13. Flashman E, Redwood C, Moolman-Smook J, Watkins H. Cardiac myosin binding protein c: its role in physiology and disease. Circ Res 2004;94:1279-1289.
14. Kunst G, Kress KR, Gruen M, Uttenweiler D, Gautel M, Fink RHA. Myosin binding protein c, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin s2. Circ Res 2000;86:51-58.
15. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 1999;44:20-36.
16. Idowu SM, Gautel M, Perkins SJ, Pfuhl M. Structure, stability and dynamics of the central domain of cardiac myosin binding protein c (mybp-c): implications for multidomain assembly and causes for cardiomyopathy. J Mol Biol 2003;329:745-761.
17. Oakley CE, Hambly BD, Curmi PMG, Brown LJ. Myosin binding protein c: structural abnormalities in familial hypertrophic cardiomyopathy. Cell Res 2004;14:95-110.
18. 2+-calmodulin- dependent protein kinases. J Biol Chem 1984;259:15587-15596.
19. Singh L, Oakley C, Brown LJ, Hambly B. Structural effects of hypertrophic cardiomyopathy mutations on sarcomeric proteins. Biophys J 2003;84:2201-Pos.
20. Morner S, Richard P, Kazzam E, Hellman U, Hainque B, Schwartz K, Waldenstrom A. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J Mol Cell Cardiol 2003;35:841-849.
21. Clarke J, Cota E, Fowler SB, Hamill S. Folding studies of immunoglobulin-like β-sandwich proteins suggest that they share a common folding pathway. Structure 1999;7:1145-1153.
22. Matysiak S, Clementi C. Optimal combination of theory and experiment for the characterization of the protein folding landscape of S6: how far can a minimalist model go? J Mol Biol 2004;343:235-248.
23. Riddle DS, Grantcharova VP, Santiago JV, Aim E, Ruczinski I, Baker D. Experiment and theory highlight role of native state topology in sh3 folding. Nat Struct Biol 1999;6:1016-1024.
24. Chiti F, Taddei N, White PM, Bucciantini M, Magherim F, Stefani M, Dobson CM. Mutational analysis of acylphosphatase suggests the importance of topology and contact order in protein folding. Nat Struct Biol 1999;6:1005-1009.
25. Plaxco KW, Simons KT, Baker D. Contact order, transition state placement and the refolding rates of single domain proteins. J Mol Biol 1998;277:985-994.
26. Cecconi F, Micheletti C, Carloni P, Maritan A. The structural basis of antiviral drug resistance and role of folding pathways in HIV-1 protease. Proteins Struct Funct Genet 2001;43:365-372.
27. Micheletti C, Cecconi F, Flammini A, Maritan A. Crucial stages of protein folding through a solvable model: Predicting target sites for enzyme-inhibiting drugs. Protein Sci 2002;11:1878-1887.
28. Hoang TX, Cieplak M. Sequencing of folding events in Go-type proteins. J Chem Phys 2000;113:8319-8328.
29. Cecconi F, Guardiani C, Livi R. Testing simplified protein models of the hpin1 ww domain. Biophys J 2006;91:694-704.
30. Kouza M, Chang CF, Hayryan S, Yu T, Li MS, Huang TH, Hu CK. Folding of the protein domain hbSBD. Biophys J 2005;89:3353-3361.
31. Stoycheva AD, Brooks CL, III, Onuchic IN. Gatekeepers in the ribosomal protein S6: thermodynamics, kinetics, and folding pathways revealed by a minimalist protein model. J Mol Biol 2004;340:571-585.
32. Clementi C, Nymeyer H, Onuchic JN. Topological and energetic factors: what determines the structural details of the transition state ensemble and "en-route" intermediates for protein folding? J Mol Biol 2000;298:937-953.
33. Evans DJ, Hoover WG, Failor BH, Moran B, Ladd AJC. Non-equilibrium molecular dynamics via gauss's principle of least constraint. Phys Rev A 1983;28:1016-1021.
34. Miyazawa S, Jernigan RL. Estimation of effective interrresidue contact energies from protein crystal structures: quasi-chemical approximation. Macromolecules 1985;18:534-552.
35. Karanicolas J, Brooks CL, III. The origins of asymmetry in the folding transition states of protein L and protein G. Protein Sci 2002;11:2351-2361.
36. Serrano L, Kellis J, Cann P, Matouschek A, Fersht A. The folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability. J Mol Biol 1992;224:783-804.
37. Kurochkina N, Lee B. Hydrophobic potential by pairwise surface area sum. Protein Eng 1995;8:437-442.
38. Richards FM, Lee B. The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971;55:379-400.
39. Sung S. Monte-Carlo simulations of β-hairpin folding at constant temperature. Biophys J 1999;76:164-175.
40. Zhou H, Zhou Y. Quantifying the effect of burial of amino acid residues on protein stability. Proteins Struct Func Bioinf 2004;54:315-322.
41. Vendruscolo M, Dokholyan NV, Paci E, Karplus M. Small-worls view of the amino acids that play a key role in protein folding. Phys Rev E 2002;65:61910-61913.
42. Dijkstra EW. A note on two problems in connexion with graphs Numer Math 1959;1:269-271.
43. Kaya H, Chan HS. Polymer principles of protein calorimetric two-state cooperativity. Proteins Struct Func Genet 2000;40:637-661.
44. Zhou Y, Hall CK, Karplus M. The calorimetric criterion for a two-state process revisited. Protein Sci 1999;8:1064-1074.
45. Hamill SJ, Steward A, Clarke J. The folding of an immunoglobulin-like greek key protein is defined by a common-core nucleus and regions constrained by topology. J Mol Biol 2000;297:165-178.
46. Kabsch W. Solution for best rotation to relate two sets of vectors. Acta Crystallogr 1976;32:922-923.
47. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982;157:105-132.
48. Dunker AK, Garner F, Guilliot S, Romero P, Albrecht K, Hart J, Obradovic Z, Kissinger C, Villafranca JE. Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac Symp Biocomput 1998;3:473-484.
49. Garner E, Cannon P, Romero P, Obradovic Z, Dunker AK. Predicting disordered regions from amino acid sequence: common themes despite differing structural characterization. Genome Inform 1998;9:201-214.
50. Romero P, Obradovic Z, Kissinger CR, Villafranca JE, Garner E, Guilliot S, Dunker AK. Thousands of proteins likely to have long disordered regions. Pac Symp Biocomput 1998;3:437-448.
51. Uversky VN, Gillespie JR, Fink AL. Why are "natively unfolded" proteins unstructured under physiologic conditions? Protein Struct Funct Genet 2000;41:415-427.
52. Uversky VN. Natively unfolded proteins: a point where biology waits for physics. Protein Sci 2002;11:739-756.
53. Garbuzynskiy SO, Lobanov MY, Galzitskaya OV. To be folded or to be unfolded? Protein Sci 2004;13:2871-2877.
54. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 1999;44:20-36.
55. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorilation switches specific for the cardiac isoform of myosin binding protein-c: a modulator of cardiac contraction? EMBO J 1995;14:1952-1960.